Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
BD Q2 Fiscal 2026 Earnings Call - Biologics Revenue Hits 55% as New CFO Vitor Roque Takes the Helm
BD delivered a solid second quarter of fiscal 2026, with revenue of $4.7 billion, up 2.6% year-over-year, and adjusted EPS of $2.90, beating expectations. The results were driven by broad-based growth...
- Revenue of $4.7 billion rose 2.6% year-over-year, with adjusted EPS of $2.90 beating expectations and full-year guidance raised to $12.52-$12.72.
- Biologics now account for 55% of Biopharma Systems revenue, driven by strong demand for GLP-1 delivery devices and new deals with major pharmaceutical companies.
- More than 90% of the portfolio delivered mid-single-digit growth, with double-digit gains in biologic drug delivery, advanced patient monitoring, PureWick, and advanced tissue regeneration.
- +7 more takeaways
Codere Online Q1 2026 Earnings Call - EBITDA Surges as Mexico and Spain Drive Top-Line Growth and Margin Expansion
Codere Online delivered a strong start to 2026 with Q1 net gaming revenue up 13% year-over-year to EUR 64.4 million, driven by robust growth in its core markets of Mexico and Spain. The company report...
- Q1 2026 net gaming revenue reached EUR 64.4 million, a 13% year-over-year increase and 6% sequential growth, confirming momentum from late 2025.
- Adjusted EBITDA surged to EUR 6 million from EUR 1.8 million in Q1 2025, reflecting a significant margin expansion to approximately 9%.
- Mexico remains the largest market, contributing 53% of LTM NGR with EUR 34.6 million in Q1, up 13.4% year-over-year.
- +7 more takeaways
Datadog Q1 2026 Earnings Call - Record Revenue Acceleration and AI Training Expansion
Datadog delivered a blowout first quarter, posting $1.01 billion in revenue, a 32% year-over-year acceleration that cleared the high end of guidance. The company added a record $53 million in sequenti...
- Total revenue reached $1.01 billion, up 32% year-over-year and above the high end of guidance.
- Sequential revenue growth hit a record $53 million, the highest Q1 add in company history.
- Non-AI customer revenue growth accelerated to the mid-20s%, signaling broad cloud migration and AI adoption beyond pure AI-native firms.
- +7 more takeaways
Madison Square Garden Entertainment Corp. Q3 FY2026 Earnings Call - Concert Momentum and Residency Pipeline Drive Growth Outlook
MSG Entertainment reported $246 million in Q3 FY2026 revenue, up 2% year-over-year, driven by strong concert demand at The Garden and growth in suite licensing and the Christmas Spectacular. Adjusted ...
- Revenue reached $246.3 million, a 2% year-over-year increase, fueled by higher entertainment offerings revenue and suite licensing growth.
- Adjusted operating income declined to $46 million, down $12 million year-over-year, primarily due to unexpected healthcare cost spikes and elevated SG&A expenses.
- Concert demand at The Garden remains robust, with a vast majority of shows selling out and food and beverage per capita spending rising.
- +7 more takeaways
Gladstone Capital Corporation Q2 2026 Earnings Call - Portfolio Yield Resilience Driven by Lower Middle Market Discipline
Gladstone Capital delivered another resilient quarter, with net investment income rising 116% to $11.8 million and NAV per share climbing to $21.36. The firm’s disciplined focus on the lower middle ma...
- Net investment income surged 116% quarter-over-quarter to $11.8 million, driven by prepayment fees and portfolio appreciation that more than covered the $0.15 monthly distribution.
- NAV per share rose to $21.36, up from $21.13, as unrealized appreciation in three scaling portfolio companies offset broader market repricing.
- The firm maintains zero direct SOFR exposure, insulating its floating-rate assets from short-term rate volatility and reducing margin pressure.
- +7 more takeaways
Aspen Aerogels Q1 2026 Earnings Call - Energy Industrial Growth Offsets Plant Disruption
Aspen Aerogels reported a challenging start to 2026, with Q1 revenue declining 8% quarter-over-quarter to $37.9 million, weighed down by an operational disruption at its East Providence manufacturing ...
- Q1 2026 revenue came in at $37.9 million, an 8% quarter-over-quarter decline, with Energy Industrial down 15% and Thermal Barrier flat.
- An explosion at the East Providence manufacturing facility in April caused a temporary operational disruption, with a staged restart expected in May.
- Energy Industrial segment targets 20% revenue growth for 2026, driven by subsea projects, LNG infrastructure expansion, and deferred maintenance work.
- +7 more takeaways
Gogo Inc Q1 2026 Earnings Call - Galileo and 5G momentum offset legacy revenue decline with record equipment sales and military growth
Gogo Inc delivered a transitional first quarter in 2026, with total revenue holding steady at $226.3 million despite a 5% year-over-year decline in service revenue. The company is actively pivoting fr...
- Total revenue of $226.3 million decreased just 2% year-over-year, demonstrating resilience amid a structural transition from legacy services to new platforms.
- Equipment revenue surged 22% to $38.6 million, driven by record sales of C1 conversion units and early shipments of the Galileo LEO network.
- Galileo LEO shipments reached 92 units in Q1, bringing cumulative shipments to 410 across 35 STCs covering a 7,000-aircraft addressable market.
- +9 more takeaways
Americold Realty Trust Q1 2026 Earnings Call - $1.1B EQT Joint Venture Drives Deleveraging Amid Stabilizing Demand
Americold Realty Trust delivered a solid first quarter, beating consensus on AFFO per share and demonstrating that demand in the cold storage sector is stabilizing. The standout move of the quarter is...
- AFFO beat consensus: Americold reported AFFO per share of $0.29, beating analyst estimates and marking the third consecutive quarter of meeting or exceeding guidance.
- EQT joint venture: Management announced a $1.3 billion joint venture with EQT Partners. Americold will contribute 12 U.S. facilities, sell a 70% stake, and receive $1.1 billion in cash proceeds to pay down debt.
- Deleveraging trajectory: The transaction is expected to reduce the net debt to pro forma Core EBITDA ratio by roughly 0.75x, bringing leverage toward the long-term target of 6x or less.
- +7 more takeaways
Lantheus Holdings Q1 2026 Earnings Call - PYLARIFY TruVu Approval and Strategic Shift to Radio Diagnostics
Lantheus Holdings reported a solid first quarter of 2026, driven by disciplined commercial execution across its core radiodiagnostics portfolio. PYLARIFY volume grew 5.8% year-over-year, NeuraCeq reve...
- PYLARIFY U.S. volume increased 5.8% year-over-year, maintaining market leadership in PSMA PET imaging despite competitive pressures and pricing discipline.
- FDA approved PYLARIFY TruVu, a new PSMA PET formulation with larger batch sizes and enhanced stability, enabling broader geographic reach via high-energy cyclotrons.
- Tentative FDA approval received for PNT2003, the first radioequivalent to LUTATHERA for GEP-NETs, with final approval pending Hatch-Waxman stay resolution and legal proceedings.
- +7 more takeaways
The Real Brokerage Q1 2026 Earnings Call - Record Cash and RE/MAX Acquisition Signal Platform Scale
The Real Brokerage delivered a resilient Q1 2026, posting $466 million in revenue, up 32% year-over-year, and growing closed transactions 25% despite a soft housing market. Adjusted EBITDA surged 80% ...
- Revenue surged 32% year-over-year to $466 million, driven by a 25% increase in closed transactions that outperformed flat U.S. and declining Canadian home sales.
- Adjusted EBITDA jumped 80% to $14.9 million, demonstrating significant operating leverage as gross profit grew faster than operating expenses.
- The company ended the quarter with a record $62.9 million in unrestricted cash and investments, maintaining a debt-free balance sheet.
- +7 more takeaways